EBCOG Part 1-Postnatal Care & Sexual Reproductive Health-Day 4(SBA)

A 34-year-old woman with a BMI of 29, who has been taking enalapril for essential hypertension, requests the combined oral contraceptive pill. Her BP is well controlled on this treatment and today is 134/88 mm Hg. To which UK Medical Eligibility Criteria would well- controlled hypertension be considered? Options

A. 1.
B. 2.
C. 3.
D. 4.
E. 5.

2.A 26-year-old woman sought contraceptive advice, and after considering all her options,she decided to start on the combined oral contraceptive pill. As you have to advise her on the best method of using these pills, you are giving her some directions. Which of the following statements is incorrect in this regard?

A. If you start the pill on the first day of your period, you will be protected from pregnancy immediately.
B. If you start the pill at any other time in your menstrual cycle, you will need to use additional contraception, such as condoms, for the first 7 days of pill taking.
C. If you miss one pill anywhere in your pack or start the new pack 1 day late, you will need to use additional contraception, such as condoms, for the first 7 days of pill taking.
D. You can also start the pill up to, and including, the fifth day of your period and you will be protected from pregnancy immediately.
E. You can start the pill any time in your menstrual cycle if you are sure you are not pregnant

3.Which of the following is true regarding Qlaira?

A. Qlaira contains estradiol valerate and desogestrel.
B. Qlaira has continuous 28 days cycle with 26 active pills with decreasing oestro- gen and increasing progesterone dose followed by 2 placebos.
C. There are clinically significant benefits over the pills containing synthetic oestrogen.
D. This is a triphasic pill.
E. While taking Qlaira if the pills are missed, the same pills rules apply as other combined oral contraceptive pills.

4.In the United Kingdom, which synthetic oestrogen is contained in most combined oral contraceptive (COC) pills?

A. Cyproterone acetate
B. Drospirenone
C. Ethinylestradiol
D. Oestradiol valerate
E. Mestranol

5. What is the background rate of venous thromboembolism (VTE) in women of reproductive age?

A. 10/100,000/year
B. 20/100,000/year
C. 50/100,000/year
D. 100/100,000/year
E. 200/100,000/year

6.A woman switches from a COC pill containing ethinyloestradiol and levonorgestrel to a different pill containing ethinyloestradiol and desogestrel. The dose of ethinyloestradiol is thesame in both preparations.Approximately, by how many times will she have increased her risk of VTE?

A. 2
B. 5
C. 10
D. 15
E. 20

7.What is the primary mode of action by which the COC pill exerts its contraceptive effect?

A. Endometrial atrophy
B. Inhibition of ovulation
C. Sperm immobilisation
D. Suppression of meiosis
E. Thickening of cervical mucus

8-A 23-year-old woman is using male and female barrier contraception to prevent sexually transmitted infections (STIs). She wants to know if there is further protection if a spermicide is included.What will you tell her regarding spermicidal creams and STIs?

A. Does not offer added protection.
B. Does not offer any protection against HIV.
C. Offers added protection.
D. Offers specific protection against HIV.
E. Protects against some types of sexually transmitted infections.

A 26-year-old woman consults you. She was at a hen party and may have had unprotected sex. She wants to make sure she did not acquire any sexually transmitted infections. She wantsto know when she should be tested.What will you tell her?

A. After two weeks.
B. After four weeks.
C. After eight weeks.
D. After 14 weeks.
E. Immediately.

A 32-year-old woman consults you about the risk of venous thrombosis if she uses a combined hormonal contraceptive. She shows you a brand, which contains 35 μg ethinylestradiol and norethisterone progestogen. How will you counsel her?

A. She should change to an intrauterine contraceptive device.
B. She should change to another oral contraceptive, which contains one of the new progestogens.
C. Her current pill has the lowest risk of blood clotting.
D. Her current pill has the highest risk of blood clotting.
E. Use it for one year only.

11. A 36-year-old woman consults you about her contraception. She is seeking a method with the lowest risk of thrombosis. She has a family history of venous thromboembo- lism (VTE) in a first-degree relative aged under 45 years. She is not keen on any intrauterine devices.mHow will you counsel her?

A. All methods have a risk of VTE.
B. If she herself has no personal history of any clotting, then all methods have the same risk.C. If she has a family history of VTE, she should have a thrombophilia screen first.
C. If she has a family history of VTE, she should have a thrombophilia screen first.
D. It is safe to use any progestogen-only method.
E. Permanent long-acting contraception is her only option.

A woman who weighs 100 kg wants to start the combined transdermal patch (CTP) for contraception.What is your advice?

A. Efficacy may be decreased because of her weight; she should use additional precautions or an alternative method should be advised.
B. It is as effective as the oral combined pill.
C. It is not effective because of her weight.
D. It is as effective as any other hormonal method, if she can guarantee compliance with the correct method of use.
E. She would be better using a non-hormonal contraceptive.

13.A 28-year-old woman consults you about combined hormonal contraception (CHC). Her mother died of breast cancer at the age of 55 years. She is healthy but has a problem with painful periods.What will you tell her?

A. Combined hormonal contraception is contraindicated because of her family history.
B. She can use it for only one year where the risk decreases after one year of use.
C. She is at no risk and it will help her period pains.
D. She can use it, but with breast screening every six months.
E. She cannot use it if she has breastfed before.

14.An 18-year-old woman asks about contraception. She has acne and complains of heavy bleeding.How will you help her to choose?

A. She can have the low-dose 13.5 mg levonorgestrel intrauterine device (IUD) to avoid acne exacerbation.
B. She can use the higher-dose 52 mg levonorgestrel for better control of her heavy bleeding.
C. She is better with a copper IUD because it has no hormones.
D. She can use a product with cyproterone acetate (CPA/EE).
E. She can try the progesterone-only pill.

A healthy 47-year-old woman comes for contraception counselling. She was under the impression that the combined hormonal contraception (CHC) method is contraindi- cated at her age.How will you counsel her?

A. Age alone is not a contraindication to any method.
B. Agree with her that combined hormonal contraception is contraindicated.
C. She can use it for only one year to avoid complications.
D. Tell her that the transdermal patch is the safest method because it is not metab- olized by the liver.
E. Tell her that the vaginal ring is more suitable.

Name*	You must fill out this field.
Phone*	You must fill out this field.
Email*	You must fill out this field.

EBCOG Part 1-Postnatal Care & Sexual Reproductive Health-Day 4(SBA)

Quiz Summary

Information

Results

Results

Categories

1. Question

2. Question

3. Question

4. Question

5. Question

6. Question

7. Question

8. Question

9. Question

10. Question

11. Question

12. Question

13. Question

14. Question

15. Question